CNBC

Hims & Hers plummets 15% after first-quarter loss, weak earnings guidance

12 5 月, 2026

One Min Read

6 Views

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

原文: https://www.cnbc.com/2026/05/12/hims-hers-plummets-16percent-after-first-quarter-loss-weak-guidance-.html

Last Update: 12 5 月, 2026

Written By

Other Articles

Previous

AI super rally has retail investors acting the most aggressive since trading frenzy during Covid

Next

<div>UK MPs are turning on PM Starmer — Now analysts say he’s unlikely to last the year</div>

Related Posts

Retail investors are running head first into this topsy-turvy market

1 Min Read

Third Point, D.E. Shaw obtain agreements with CoStar. How the activists can build value

1 Min Read

Top Wall Street analysts find these 3 stocks attractive in these challenging times

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept